New Research Links Gabapentin to Dementia
Recent studies have raised concerns about a potential link between long-term gabapentin use and an increased risk of dementia and cognitive decline. One notable study analyzed electronic health records of over 52,000 adults suffering from chronic low back pain. Researchers found that patients who had received six or more prescriptions of gabapentin had a 29% higher risk of developing all-cause dementia and an 85% increased risk of mild cognitive impairment (MCI) compared to those who never took the drug.
The study revealed that the risks were particularly significant in individuals aged 35 to 64, while no increased risk was found in patients under 35. In the 35–49 age group, dementia risk more than doubled, and MCI risk tripled. A dose-response relationship was also observed: those with twelve or more prescriptions showed an even greater increase in dementia risk compared to those with fewer prescriptions.
Limitations and Interpretation of the Findings
It’s important to emphasize that the study was observational in nature, meaning it can show association but not prove that gabapentin directly causes dementia. Researchers tried to account for variables such as age, comorbid conditions, and other medications, but they could not adjust for every possible confounding factor, such as lifestyle or severity of pain.
Some experts also caution that early cognitive changes might lead to more frequent prescriptions of gabapentin—a phenomenon known as reverse causality. Another complicating factor is that chronic pain itself has been associated with an elevated risk of dementia. Therefore, it’s unclear how much of the increased risk is due to gabapentin specifically, and how much stems from the underlying conditions being treated.
Biological Plausibility
Gabapentin affects the central nervous system by modifying neurotransmitter activity, which helps reduce nerve pain and seizures. However, these same effects may alter brain function in ways that could contribute to cognitive decline. Common side effects of gabapentin include drowsiness, confusion, memory problems, and difficulty concentrating—symptoms that may reflect changes in cognitive function.
In older adults, especially, these side effects can be pronounced. A separate study tracking cognitive performance in elderly patients taking gabapentin found a measurable decline in test scores related to memory and daily functioning. This adds biological credibility to the concern that long-term gabapentin use could impair brain health.
What Patients and Providers Should Do
Given these emerging concerns, healthcare professionals are encouraged to review long-term gabapentin prescriptions, particularly in middle-aged and older adults. Gabapentin should not be discontinued suddenly, especially if it’s being used to manage chronic pain or seizures. Instead, any changes to dosage or medication should be supervised by a physician.
Doctors may consider alternative pain management strategies, such as physical therapy, non-pharmacological treatments, or medications with fewer cognitive side effects. Regular monitoring for signs of memory issues or confusion should also be part of ongoing treatment for patients on long-term gabapentin.
Conclusion
Gabapentin remains a valuable treatment for many conditions, especially nerve pain and seizures. However, mounting evidence suggests a potential link between prolonged gabapentin use and increased dementia risk, especially in adults aged 35 to 64. While further research is needed to determine causality and understand the mechanisms involved, patients and healthcare providers should approach long-term gabapentin use with increased caution, especially when safer alternatives are available.
Our Products
-
Amoxicillin Dosage – 250mg
$1.00 / Per Pill
-
Amoxicillin Capsules 500MG
$1.25 / Per Pill
-
Azithromycin 250MG
$2.00 / Per Pill
